Medgenics Inc (NYSE MKT LLC:MDGN)

7.84
Delayed Data
As of Feb 27
 -0.23 / -2.85%
Today’s Change
3.68
Today|||52-Week Range
8.80
+54.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-8.1M-15.1M-17.1M-18.4M
 
 
 
 
 
Depreciation98.0K145.0K177.0K225.0K
 
 
 
 
 
Total Other Cash Flow-1.2M3.0M3.6M5.5M
 
 
 
 
 
Funds From Operations-9.2M-11.9M-13.3M-12.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.2M-3.3M-574.0K-511.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-8.0M-8.6M-12.7M-12.2M
 
 
 
 
 
 
InvestingCapital Expenditures-289.0K-63.0K-186.0K-364.0K
 
 
 
 
 
Fixed Asset Disposal0.000.003.0K1.0K
 
 
 
Other Investing - Uses-10.0K-5.0K0.000.00
 
 
 
Net Cash Flow Investing-299.0K-68.0K-183.0K-363.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale10.5M10.1M28.9M23.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing10.5M10.1M28.9M23.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash2.1M1.4M16.0M10.9M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account